23 studies found for: Open Studies | "Leukemia, Hairy Cell"
Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies
Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies
† Study has passed its completion date and status has not been verified in more than two years.